Home » Authors » Rainer B. Langen

Articles by Rainer B. Langen

Co.don Taking Cell Platform Public On Market In Germany

Feb. 7, 2001

By Rainer B. Langen

German Government Commits DM1.5B To Biotech Research

Jan. 31, 2001

By Rainer B. Langen

GPC, Byk Gulden Collaborate In Deal Worth Up To US$100M

Jan. 24, 2001

By Rainer B. Langen

MorphoSys Enters EUR22M Deal With Centocor Around HuCAL

Jan. 10, 2001

By Rainer B. Langen

Xantos Formed Around Platform To Perform Functional Genomics

Jan. 10, 2001

By Rainer B. Langen

MediGene's Genital Warts Drug Enters Phase III Clinical Trials

Jan. 10, 2001

By Rainer B. Langen

LION Adds Preclinical Capability Through $35M Trega Acquisition

Jan. 3, 2001

By Rainer B. Langen

Estonia Will Build National Gene Bank With SNPs Of 1M Citizens

Jan. 3, 2001

By Rainer B. Langen

Germans React To British Decision On Embryonic Stem Cell Cloning

Jan. 3, 2001

By Rainer B. Langen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...